Your session is about to expire
← Back to Search
Modified Heidelberg Model of Neuro-Music Therapy for Germ Cell Cancer
Study Summary
This trial is testing a new therapy for tinnitus and cancer that involves music. They are testing how well patients can tolerate the therapy and follow the instructions.
- Relapsed Germ Cell Cancer
- Tinnitus
Timeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Frequently Asked Questions
What goals is this medical study striving to accomplish?
"The primary assessment of this trial covers a period up to two years, and is focused on the success of recruitment. Secondary outcomes include an analysis of anxiety levels via the Impact Events Scale (0-4), severity in tinnitus observed on the Tinnitus Functional Index (1-10) as well as associated distress captured through the Tinnitus Questionnaire (0-82)."
How many participants has this clinical trial recruited to date?
"Affirmative. According to the clinicaltrials.gov website, this medical experiment is actively seeking volunteers and was initially posted on December 2nd 2019 with its most recent update being June 8th 2022. At present, they need 15 patients at a single site for participation."
Are there any eligibility requirements to join the current clinical trial?
"As evidenced on clinicaltrials.gov, this trial is currently accepting applicants. It was first advertised on December 2nd 2019 and has been revised as recently as June 8th 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
Share this study with friends
Copy Link
Messenger